PET/MRI融合显像在脑胶质瘤诊断和治疗中的研究进展

高艳; 赵晋华; 高艳; 赵晋华

doi:10.3760/cma.j.issn.1673-4114.2015.01.015

[1]

Zene Q S,Liu H P,Zhang K,et a1.Noninvasive evaluation of cere-bral glioma grade by using multivoxel 3D proton MR spectroscopy[J].Magn Reson Imaging,2011,29(1):25-31.

[2]

Bai X,Zhang Y T,Liu Y,et al.Grading of supratentorial astrocytic tumors by using the difference of ADC value[J].Neuroradiology,2011,53(7):533-539.

[3]

Server A,Kulle B,Gadmar ØB,et al.Measurements of diagnostic examination performance using quantitative apparent diffusion coefficient and proton M R spectroscopic imaging in the preoperative evaluation of tumor grade in cerebral gliomas[J].Eur J Radiol,2011,80(2):462-470.

[4]

Arvinda HR,Kesavadas C,Sarma PS,et al.Glioma grading:sensi-tivity,specificity,positive and negative predictive values of diffu-sion and perfusion imaging[J].J Neurooncol,2009,94(1):87-96.

[5]

Saitta L,Heese O,Förster AF,et al.Signal intensity in T2' magnetic resonance imaging is related to brain glioma grade[J].Eur Radiol,2011,21(5):1068-1076.

[6]

Padma MV,Said S,Jacobs M,et al.Prediction of pathology and survival by FDG PET in gliomas[J].J Neurooneol,2003,64(3):227-237.

[7]

程勋全,钱立庭.PET/CT显像剂在脑胶质瘤中的应用研究进展[J].中国实验诊断学,2009,13(9):1308-1310.

[8]

蔡莉,李彦生.氟代脱氧葡萄糖与氨基酸PET在脑肿瘤中的对比研究[J].国外医学:放射医学核医学分册,2005,29(1):10-14.

[9]

韩志铁,苏少波,雪亮,等.¹¹C-METPET与MRI影像融合技术在胶质瘤术前评价和术中导航中的应用价值[J].中国现代神经疾病杂志,2013,13(4):324-329.

[10]

Pöpperl G,Kreth FW,Mehrkens JH,et al.FET PET for the evalua-tion of untreated gliomas:correlation of FET uptake and uptake kinetics with tumor grading[J].Eur J Nucl Med Mol Imaging,2007,34(12):1933-1942.

[11]

Mertens K,Acou M,Van Hauwe J,et al.Validation of ¹⁸F-FDG PET at conventional and delayed intervals for the discrimination of high-grade from low-grade gliomas:a stereotactic PET and MRI study[J].Clin Nucl Med,2013,38(7):495-500.

[12]

Holodny AI,Makeyev S,Beattie BJ,et al.Apparent diffusion coef-ficient of glial neoplasms:correlation with fluorodeoxyglucose-e-mission tomography and gadolinium-enhanced MR imaging[J].AJNR A m J Neurodiol,2010,31(6):1042-1048.

[13]

Gempt J,Soehngen E,Forster S,et al.Multimodal imaging in cere-bral gliomas and its neuropathological correlation[J].Eur J Radi-ol,2014,83(5):829-834.

[14]

Rahm V,Boxheimer L,Bruehlmeier M,et al.Focal changes in dif-fusivity on apparent diffusion coefficient MR imaging and amino acid uptake on PET do not colocalize in nonenhancing low-gradegliomas[J].J Nucl Med,2014,55(4):546-550.

[15]

Kelly PJ,Daumas-Duport C,Scheithauer BW,et al.Stereotactic histologic correlations of computed tomography-and magnetic reso-nance imaging-defined abnormalities in patients with glial neo-plasms[J].Mayo Clin Proc,1987,62(6):450-459.

[16]

Pauleit D,Floeth F,Hamacher K,et al.O-(2-¹⁸F-fluoroethy)-L-ty-rosine PET combined with MRI improves the diagnostic assessment of cerebral gliomas[J].Brain,2005,128(pt3):678-687.

[17]

Tanaka Y,Nariai T,Momose T,et al.Glioma surgery using a multi-modal navigation system with integrated metabolic images[J].J Neurosurg,2009,110(1):163-172.

[18]

Miwa K,Shinoda J,Yano H,et al.Discrepancy between lesion dis-tributions on methionine PET and M R images in patients with glioblastoma multiforme:insight from a PET and MR fusion image study[J].J Neurol Neurosury Psychiatry,2004,75(10):1457-1462.

[19]

郭旭,郭毅,程欣,等.PET-MRI影像融合技术在胶质瘤的活组织检查和手术中的应用[J].中华医学杂志,2013,93(1):15-18.

[20]

邓美玲,吴少雄,黄绍敏,等.11C-MET PET和MRI对脑高级别神经胶质瘤术后放疗靶区设定的比较研究[J].中华放射肿瘤学杂志,2010,19(5):415-419.

[21]

Braun V,Dempf S,Weller R,et al.Cranial neuronavigation with di-rect integration of 11C methionine positron emission tomography(PET) data-results of a pilot study in 32 surgical cases[J].Acta Neurochir(Wien),2002,144(8):777-782.

[22]

Pirotte B,Goldman S,Massager N,et al.Combined use of [F-18] fluorodeoxyglucose and[C-11] methionine in 45 PET-guided stereo-tactic brain biopsies[J].J Neurosurg,2004,101(3):476-483.

[23]

Pirotte B,Goldman S,Massager N,et al.Comparison of ¹⁸F-FDG and 11C-methionine for PET-guided stereotactic brain biopsy in gliomas[J].J Nucl Med,2004,45(8):1293-1298.

[24]

Navarria P,Reggionri G,Pessina F,et al.Investigation on the role of integratea PET/MRI ior target volume definition and radiothera-py planning in patients with high grade glioma[J].Radiother Oncol,2014,112(3):425-429.

[25]

Filss CP,Stoffels G,Galldiks N,et al.Histogram analysis reveals a better delineation of tumor volume from background in ¹⁸F-FET PET compared to CBV maps in a hybrid PET-MR studie in gliomas[J].Nucl Instrum Methods Phy Res A,2014,734:175-178.

[26]

Rieken S,Habermehl D,Giesel FL,et al.Analysis of FET-PET imaging for target volume definition in patients with gliomas treated with conformal radiotherapy[J].Radiother Oncol,2013,109(3):487-492.

[27]

Chao ST,Suh JH,Raja S,el al.The sensitivity and specificity of FDG PET in distinguishing recurrent brain tumor from radionecro-sis in patients treated with stereotactic radiosurgery[J].Int J Cancer,2001,96(3):191-197.

[28]

Chung JK,Kim YK,Kim SK,et al.Usefulness of ¹¹C-methionine PET in the evaluation of brain lesions that are hypo-or isometabolic on ¹⁸F-FDG PET[J].Eur J Nucl Med Mol Imaging,2002,29(2):176-182.

[29]

Chen W.Clinical applications of PET in brain tumors[J].J Nucl Med,2007,48(9):1468-1481.

[30]

D,Souza MM,Sharma R,Jaimini A,et al.¹¹C-MET PET/CT and advanced MRI in the evaluation of tumor recurrence in high-grade gliomas[J].Clin Nucl Med,2014,39(9):791-798.

[31]

Grosu AL,Weber WA,Riedel E,et al.L-(methyl)¹¹C-methionine positron emission tomography for target delineation in resected highgrade gliomas before radiotherapy[J].Int J Radiat Oncol Biol Phys,2005,63(1):64-74.

[32]

Galldiks N,Stoffels G,Ruge MI,et al.Role of O-(2-¹⁸F-Fluo-roethyl)-L-tyrosine PET as a diagnostic tool for detection of mali-gant progression in patients with low-grade glioma[J].J Nucl Med,2013,54(12):2046-2054.

[33]

Jansen NL,Schwartz C,Graute V A,et al.Prediction of oligoden-droglial histology and LOH 1p/19q using dynamic[¹⁸F] FET-PETimaging in intracranial W H O grade Ⅱ and Ⅲ gliomas[J].NeuroOncol,2012,14(12):1473-1480.

[34]

Niyazi M,Jansen N,Ganswindt U,et al.Re-irradiation in recurrent malignant glioma:prognostic value of[¹⁸F] FET-PET[J].J Neuroon-col,2012,110(3):389-395.

[35]

Galldiks N,Rapp M,Stoffels G,et al.Response assessment of beva-cizumab inpatients with recurrent malignant glioma using[¹⁸F] Fluo-roethyl-1-tyrosine PET in comparison to MRI[J].Eur J Nucl Med Mol Imaging,2013,40(1):22-33.